A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults-Reference-Cited by-同舟云学术

A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults

Published:2013-06-01 Issue:6 Volume:98 Page:2595-2603
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Yuen Kevin C. J.¹,Conway Gerard S.²,Popovic Vera³,Merriam George R.⁴,Bailey Timothy⁵,Hamrahian Amir H.⁶,Biller Beverly M. K.⁷,Kipnes Mark⁸,Moore Jerome A.⁹,Humphriss Eric¹⁰,Bright George M.¹⁰,Cleland Jeffrey L.¹⁰

Affiliation:

1. Endocrinology, Diabetes and Clinical Nutrition (K.C.J.Y.), Oregon Health and Science University, Portland, Oregon 97239

2. Endocrinology (G.S.C.), University College London Hospitals, London NW1 2BU, United Kingdom

3. Faculty of Medicine (V.P.), University of Belgrade and Department of Neuroendocrinology, Clinical Center Serbia, 11000 Belgrade, Serbia

4. VA Puget Sound Health Care System and Metabolism, Endocrinology and Nutrition (G.R.M.), University of Washington School of Medicine, Seattle and Tacoma, Washington 98493

5. AMCR Institute (T.B.), Escondido, California 92026

6. Cleveland Clinic Foundation (A.H.H.), Cleveland, Ohio 44195

7. Neuroendocrine Unit (B.M.K.B.), Massachusetts General Hospital, Boston, Massachusetts 02114

8. Endocrinology, Diabetes & Glandular Disease Clinic (M.K.), San Antonio, Texas 78229

9. Pacific Biodevelopment, LLC (J.A.M.), Emeryville, California 94608

10. Versartis, Inc (E.H., G.M.B., J.L.C.), Redwood City, California 94065

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/98/6/2595/20288473/jcem2595.pdf

Reference38 articles.

1. Compliance and persistence in pediatric and adult patients receiving growth hormone therapy;Rosenfeld;Endocr Pract,2008

2. Patient outcomes in the GHMonitor: the effect of delivery device on compliance and growth;Desrosiers;Pediatr Endocrinol Rev,2005

3. Monitoring of concordance in growth hormone therapy;Kapoor;Arch Dis Child,2008

4. Human growth hormone therapy: poor adherence equals poor growth;Hunter;Arch Dis Child,2000

5. Non-compliance with growth hormone treatment in children is common and impairs linear growth;Cutfield;PLoS One,2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unstructured polypeptides as a versatile drug delivery technology;Acta Biomaterialia;2023-07

2. Masking T cell engagers mitigates on-target off-tumor activity;Nature Cancer;2023-03-30

3. Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors;Nature Cancer;2023-03-30

4. XPAT® proteins, conditionally activated T-cell engagers engineered to mitigate on-target, off-tumor toxicity for immunotherapy of solid tumors;2022-09-30

5. PEGylated Recombinant Human Growth Hormone Jintrolong® Exhibits Good Long-Term Safety in Cynomolgus Monkeys and Human Pediatric Growth Hormone Deficiency Patients;Frontiers in Endocrinology;2022-07-15